RESUMO
BACKGROUND: Pain is one of the most frequent symptoms in older adults. It severely impairs quality of life, increases delirium risk, and may lead to progression of dementia. Assessment of pain performed by taking anamnesis from the patient is not reliable in patients with dementia due to cooperation and communication problems. The aim of this study was to assess pain and its consequences in patients with dementia. METHODS: Seventy-five nursing home residents with dementia were enrolled. After comprehensive geriatric assessment, presence of pain was asked to patients, and Pain Assessment in Advanced Dementia (PAINAD), Discomfort Scale for Dementia of the Alzheimer's Type (DS-DAT), Pain Assessment for the Dementing Elderly (PADE), Wong-Baker Faces Pain Rating Scale, and Numeric Rating Scale tests were performed. RESULTS: Mean age was 81.1 (7.0), and 46.7% (n = 35) were female. Thirty-two percent of the patients were at early stage, 24% at moderate stage, and 44% at severe stage. Although the number of patients declaring pain was lower in moderate and severe stage, scores of PADE, PAINAD, and DS-DAT were significantly higher in severe stage showing the presence of pain ( P < .001). Furthermore, scores of PADE, PAINAD, and DS-DAT were negatively correlated with comprehensive geriatric assessment test scores. CONCLUSION: These results demonstrate that pain is not rare in patients with dementia, but they are not usually capable of expressing it, especially in the severe stage. Therefore, objective pain assessment scales developed for patients with dementia should be routinely used and management of pain should be done regarding the association of pain with other geriatric syndromes.
Assuntos
Demência/complicações , Dor/etiologia , Qualidade de Vida/psicologia , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Dor/patologia , Medição da DorRESUMO
BACKGROUND: Malnutrition is a pitfall in older adults despite its high prevalence and serious consequences. There are various screening tests however, none of them have been validated for our country. In this study, we aimed to test the hypothesis that MNA (long form of MNA) and MNA-SF (short form of MNA) are applicable to screen malnutrition in Turkish geriatric patients. MATERIALS AND METHODS: Two hundred and thirty-six patients aged 65 years and over who were admitted to our geriatric medicine outpatient clinic were enrolled in the study. Four groups of data (anthropometric measurements, biochemical markers, three-day diet record and geriatric assessment scales) were recorded. Long and short forms of MNA test were performed. Two different geriatricians interpreted the patients' nutritional status with the aid of aforementioned data. Patients were divided into three groups which were patients with malnutrition, with malnutrition risk and well-nourished. Concordance between the two geriatricians' clinical assessment was analyzed by kappa statistics. Excellent concordance was found, therefore the first specialist's decisions were accepted as gold-standard. A third physician performed the long and short forms of MNA test. The concordance between the first clinician's assessment and MNA test results were compared subsequently. RESULTS: MNA and MNA-SF results were compared with first clinician's decision of malnutrition and kappa coefficients were 0.68 and 0.66, respectively. Sensitivity analysis indicated that MNA was 92% sensitive and 86% specific, whereas MNA-SF was 94% sensitive and 81% specific. CONCLUSION: MNA and MNA-SF are suitable for malnutrition screening in Turkish older adults.
Assuntos
Avaliação Geriátrica/métodos , Má Oclusão/diagnóstico , Programas de Rastreamento/métodos , Avaliação Nutricional , Estado Nutricional , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Incidência , Masculino , Má Oclusão/epidemiologia , Prevalência , Turquia/epidemiologiaRESUMO
OBJECTIVES: Incidences of overactive bladder (OAB) and cognitive dysfunction increase with aging. Treatment of OAB with antimuscarinic agents may result in cognitive decline, especially in patients with Alzheimer's disease (AD). The aim of this study is to evaluate the effect of antimuscarinic treatment on cognitive functions, depression, and quality of life (QOL) of patients with OAB. METHODS: This non-interventional prospective observational study was conducted in a geriatric medicine outpatient clinic. Overall, 168 OAB patients were enrolled. Patients were followed up in five groups: oxybutynin, darifenacin, tolterodine, trospium, and control groups. Follow-up visits were done at second, third, and sixth months. Comprehensive geriatric assessment, cognitive and mood assessment, QOL scales (IIQ-7, UDI-6) were performed. RESULTS: Mean age of the patients was 73.5 ± 6.1. Of the 168 patients, 92.3% were female, 83.3% benefited from the treatment, and 37.1% discontinued the medication. Discontinuation rate and frequency of side effects were more frequent in the oxybutynin group. Mini Mental State Examination scores did not decline after treatment, even in AD patients. Geriatric Depression Scale scores, Activities of Daily Living scores, and QOL scores significantly improved after treatment. CONCLUSION: Antimuscarinic agents are effective in OAB treatment. They have a positive impact on daily life activities, depression, and QOL indices. Furthermore, they do not have a negative effect on cognitive function in older adults with or without AD.
Assuntos
Transtornos Cognitivos/induzido quimicamente , Depressão/tratamento farmacológico , Antagonistas Muscarínicos/farmacologia , Qualidade de Vida/psicologia , Bexiga Urinária Hiperativa/tratamento farmacológico , Atividades Cotidianas/psicologia , Idoso , Idoso de 80 Anos ou mais , Compostos Benzidrílicos/efeitos adversos , Compostos Benzidrílicos/farmacologia , Benzilatos/efeitos adversos , Benzilatos/farmacologia , Benzofuranos/efeitos adversos , Benzofuranos/farmacologia , Cresóis/efeitos adversos , Cresóis/farmacologia , Feminino , Seguimentos , Avaliação Geriátrica , Humanos , Masculino , Ácidos Mandélicos/efeitos adversos , Ácidos Mandélicos/farmacologia , Antagonistas Muscarínicos/efeitos adversos , Nortropanos/efeitos adversos , Nortropanos/farmacologia , Fenilpropanolamina/efeitos adversos , Fenilpropanolamina/farmacologia , Pirrolidinas/efeitos adversos , Pirrolidinas/farmacologia , Tartarato de Tolterodina , Resultado do TratamentoRESUMO
BACKGROUND/AIM: Inflammation may play an important role in Alzheimer disease (AD) pathogenesis. A growing amount of evidence indicates that resistin has hallmark regulatory functions such as inflammatory states. The aim of this study was to determine whether plasma resistin levels would be useful in the diagnosis of patients with AD and to investigate the relationships between resistin and other inflammatory markers such as hs-CRP and TNF-α. Materials and methods: In this cross-sectional study, 38 AD patients and 32 control subjects with normal cognitive function aged 65 years and over were included. The diagnosis of AD was made according to DSM-IV and NINCDS-ADRDA criteria. Serum levels of resistin were measured with an enzyme-linked immunosorbent assay method using the human resistin E50 kit. Results: The median resistin level of AD patients was significantly higher than in the control group (86.3 vs. 70.8 pg/mL, P = 0.002). Overall accuracy of resistin in determining AD was 70.66%, with sensitivity, specificity, PPV, and NPV of 75.0%, 65.5%, 73.0%, and 67.9%, respectively. There was no statistically significant difference between AD patients and control subjects with respect to hs-CRP and TNF-α levels. Conclusion: Resistin levels may be considered as a predictor of AD and it may predict activation of the immune system in AD pathophysiology.
Assuntos
Doença de Alzheimer/sangue , Resistina/sangue , Idoso , Idoso de 80 Anos ou mais , Doença de Alzheimer/diagnóstico , Biomarcadores/sangue , Proteína C-Reativa/metabolismo , Estudos de Casos e Controles , Estudos Transversais , Feminino , Humanos , Inflamação , Masculino , Valor Preditivo dos Testes , Curva ROC , Fator de Necrose Tumoral alfa/sangueRESUMO
BACKGROUND/AIM: To compare plasma vitamin D concentrations among patients with normal cognitive function (control group), mild cognitive impairment (MCI), and Alzheimer disease (AD). MATERIALS AND METHODS: In total, 158 patients with AD, 228 patients with MCI, and 603 control subjects were included. Plasma levels of 25-hydroxyvitamin D were measured after comprehensive geriatric assessment and compared among groups. SPSS 15.0 was used for statistical analysis. RESULTS: Mean levels of 25-hydroxyvitamin D were significantly different among the 3 groups of AD patients, MCI patients, and controls (P < 0.001). Post hoc analysis revealed that the levels were significantly lower in the MCI group than the control group (P = 0.002) and significantly lower in the AD group than the control group (P = 0.003). Multivariate analysis showed that age (OR: 1.070, 95% CI: 1.025-1.116, P = 0.002), instrumental activities of daily living score (OR: 0.920, 95% CI: 0.850-0.995, P = 0.037), 25-hydroxyvitamin D level (OR: 0.959, 95% CI: 0.932-0.987, P = 0.004), and diabetes mellitus (OR: 2.476, 95% CI: 1.153-5.319, P = 0.020) were factors independently associated with AD. CONCLUSION: This study demonstrated that there is a correction between plasma 25-hydroxyvitamin D levels and cognitive functions.
Assuntos
Doença de Alzheimer/sangue , Disfunção Cognitiva/sangue , Vitamina D/análogos & derivados , Atividades Cotidianas , Idoso , Idoso de 80 Anos ou mais , Estudos de Casos e Controles , Estudos Transversais , Feminino , Humanos , Modelos Logísticos , Masculino , Vitamina D/sangueRESUMO
This study aimed to determine the reliability and validity of the Turkish version of Disability Assessment for Dementia (DAD) scale in the Turkish elderly population with Alzheimer disease (AD). The DAD scale was administered to the primary caregivers of 157 patients (age 77.7 ± 6.8 years) with AD. The Turkish version of the DAD scale showed high internal consistency (Cronbach α = .942), excellent test-retest, and interrater reliability (intraclass correlation coefficient [ICC] = 0.996 and ICC = 0.994, respectively). The DAD scale was significantly correlated with activities of daily living (ADL; Modified Older Americans Research Survey ADL) and instrumental activities of daily living (IADL; Lawton and Brody IADL) scales (r = .89, P < .001 and r = .90, P < .001). Disability Assessment for Dementia had a high negative correlation with the Global Deterioration Scale (GDS; r = -.880, P < .001). Post hoc comparisons with Tukey test showed significant differences in the mean DAD scores in different GDS stages. Construct validity was estimated using total score correlation analyses between the standardized Mini-Mental State Examination (MMSE) and the DAD scale. Results revealed high and significant correlation between MMSE score and DAD scale (r = .812, P < .001). The results of multivariate analysis showed that DAD score was not correlated with gender, education, and age. The DAD total score was affected mostly by GDS, MMSE, and duration of the disease. Turkish version of the DAD scale was found to be a reliable and valid instrument to assess functional disability in Turkish elderly patients with AD. This scale assists caregivers and physicians to decide for proper interventions.
Assuntos
Atividades Cotidianas , Doença de Alzheimer/diagnóstico , Cuidadores/psicologia , Avaliação da Deficiência , Avaliação Geriátrica/métodos , Inquéritos e Questionários , Idoso , Idoso de 80 Anos ou mais , Doença de Alzheimer/psicologia , Demência/diagnóstico , Demência/psicologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Testes Neuropsicológicos , Padrões de Referência , Reprodutibilidade dos Testes , Índice de Gravidade de Doença , Tradução , TurquiaRESUMO
BACKGROUND: Chronic kidney disease can lead to sarcopenia; however, no study has described sarcopenia in the patients undergoing renal transplantation. OBJECTIVES: The aim of the present study was to assess the prevalence of sarcopenia in renal transplant recipients (RTR) and to evaluate the demographic and metabolic risk factors associated with sarcopenia in these patients. PATIENTS AND METHODS: Sarcopenia was diagnosed by measuring handgrip strength in 166 RTR (68 females and 98 males; mean age, 37.9 ± 11.9 years). Basal metabolic rate, fat mass, free-fat mass, total body water, body mass index, and calf circumference were determined, along with blood biochemistry, vitamin D levels, and glomerular filtration rate. RESULTS: Among 166 patients, sarcopenia was present in 34 (20.5%). Handgrip, basal metabolic rate, free fat mass, and total body water were significantly lower in patients with sarcopenia in comparison with those without sarcopenia. There were no differences between patients with and without sarcopenia in terms of mean time since transplantation, the presence of diabetes mellitus, hypertension, coronary artery disease, hyperlipidemia, glomerular filtration rate, and body mass index. Univariate analysis revealed significant differences between patients with and without sarcopenia with respect to age (mean of 43.70 ± 13.97 and 36.37 ± 10.82 years, respectively; P = 0.007) and 25-OH vitamin D levels (median (IQR) of 12 (2-39) and 17.70 (3-68) µg/L, respectively; P = 0.024). There was a statistically significant positive correlation between vitamin D levels and handgrip strength (r = 0.334; P < 0.001). Multivariate regression analysis determined that age was an independent predictive variable of sarcopenia in RTR (ß = 1.060; 95% CI, 1.017-1.105; and P = 0.006). CONCLUSIONS: Chronic renal disease contributes to sarcopenia, which may develop at an earlier age in RTR.
RESUMO
Hydatid cyst, a human parasitic disease, remains a clinical problem in undeveloped and developing countries. Although liver and lungs are regular sites of infection, rarely other organs such as the heart can be involved. Herein, we report an isolated cardiac hydatid cyst in an 87-year-old man. He had a history of dementia for 5 years and no history for cardiac or pulmonary disease. He presented with exertional dyspnoea which continued up to 6 months. The diagnosis was made by echocardiography and computed tomography (CT). The patient was inoperable and was treated with albendazole 10 mg/kg for 6 months. After a 6-month follow-up, echocardiography revealed reduction in the size of the cyst. We believe this is the first documented case of cardiac hydatid cyst which regressed with only medical treatment in an older adult with dementia.
Assuntos
Albendazol/uso terapêutico , Anticestoides/uso terapêutico , Demência/complicações , Equinococose/tratamento farmacológico , Cardiopatias/tratamento farmacológico , Idoso de 80 Anos ou mais , Demência/diagnóstico , Equinococose/complicações , Equinococose/diagnóstico , Equinococose/parasitologia , Cardiopatias/complicações , Cardiopatias/diagnóstico , Cardiopatias/parasitologia , Humanos , Masculino , Indução de Remissão , Fatores de Tempo , Tomografia Computadorizada por Raios X , Resultado do TratamentoRESUMO
Osteoporosis is, an age related disorder, influencing elderly people worldwide. The latest data suggests that inflammation plays a critical role in bone remodeling and in pathogenesis of osteoporosis. NLR is a simple, non-invasive and cost-effective marker of inflammation in various malignancies and inflammatory diseases. The objective of the present study was to compare NLR levels in osteopenic, osteoporotic and control subjects and to assess the correlation between NLR levels and BMD. A total of 1635 patients aged 65 years or more were included in this cross-sectional study. BMD was measured by dual-energy X-ray absorptiometry (DEXA) at the lumbar spine and femur. Complete blood count (CBC), biomarkers of inflammation (C-reactive protein (CRP), erythrocyte sedimentation rate (ESR)), glucose/lipid metabolism and established risk factors were determined. In osteoporosis group, NLR levels were found to be elevated as compared to osteopenic and control group (2.54±1.45, 2.37±1.00 and 2.18±0.85, respectively). At multivariate analysis NLR emerged as independent predictor of osteoporosis (OR=1.122; 95%=1.020-1.235, p=0.018) and there was a significant negative correlation between lumbar spine (L2-L4), femoral neck scores and NLR (r=0.348, p<0.001; r=0.264, p=0.004, respectively). Elderly people with osteoporosis have elevated NLR levels, suggesting that inflammation may play an important role in bone remodeling.
Assuntos
Densidade Óssea , Contagem de Linfócitos , Neutrófilos/patologia , Absorciometria de Fóton , Idoso , Idoso de 80 Anos ou mais , Doenças Ósseas Metabólicas/diagnóstico , Feminino , Humanos , Masculino , Osteoporose/diagnósticoRESUMO
Decline in MM and MS with aging, defined as sarcopenia, is related with physical disability, poor quality of life and death. Its mechanisms are not fully understood. Testosterone increases muscle protein synthesis. However, the effects of in utero androgen exposure to MM and MS in older adults have not been studied. In utero androgen exposure is inversely related with 2D:4D ratio. The aim of this study was to investigate the relationship between 2D:4D ratio as an indicator of in utero androgen exposure and MM and MS in elderly patients. A total of 151 older adults were included. Calf-circumference (CC) and skeletal muscle mass index (SMI) were used for the assessment of MM and hand grip strength for the assessment of MS. Mean age ± SD of the patients was 73.72 ± 6.23. Fifty-two (34.4%) of patients were male, 99 (65.6%) were female. Right and left 2D:4D were significantly and negatively correlated with hand grip strength (r=-0.365, p=0.018 and r=-0.434, p=0.005, respectively), CC (r=-0.422, p=0.002 and r=-0.459, p=0.001, respectively) and SMI (r=-0.354, p=0.018 and r=-0.348, p=0.022, respectively) in men. In women, right and left 2D:4D were significantly and negatively correlated with hand grip strength (r=-0.252, p=0.022 and r=-0.234, p=0.033, respectively), CC (r=-0.229, p=0.024 and r=-0.302, p=0.003, respectively) and SMI (r=-0.382, p<0.001 and r=-0.431, p<0.001, respectively). In this study, we found that 2D:4D ratio was significantly and negatively correlated with parameters depicting MM and MS which may suggest the possible role of in utero androgen exposure in the development of MM and MS loss in the elderly.
Assuntos
Envelhecimento/fisiologia , Androgênios/efeitos adversos , Dedos/anatomia & histologia , Força da Mão/fisiologia , Exposição Materna/efeitos adversos , Força Muscular/fisiologia , Idoso , Androgênios/sangue , Antropometria , Estudos Transversais , Feminino , Humanos , Masculino , Testosterona/sangueRESUMO
Increasing evidence supports the theory that oxidative stress plays an important role in the pathogenesis of Alzheimer's disease (AD). Homocysteine (Hcy), uric acid (UA), bilirubin, and albumin are simple laboratory parameters that are related to oxidative stress. In this study we compared serum Hcy and antioxidant levels in patients with AD and normal cognitive function. In this cross-sectional study, 143 AD patients and 1,553 patients with normal cognitive function aged 65 years and over were enrolled. Mean values of UA and albumin levels of AD patients were significantly lower than normal cognitive function subjects (p: 0.003 versus p < 0.001, respectively). Mean value of Hcy levels of AD patients was significantly higher than normal cognitive function subjects (p = 0.031). Multivariate regression analysis revealed that Mini-nutritional assessment short form (OR: 0.905, 95% CI: 0.850-0.965, p = 0.002), hypertension (OR: 1.573, 95% CI: 1.148-2.155, p = 0.005), UA (OR: 0.879, 95% CI: 0.788-0.981, p = 0.021), Hcy (OR: 1.040, 95% CI: 1.022-1.059, p < 0.001), and albumin (OR: 0.505, 95% CI: 0.339-0.753, p < 0.001) were independent variables predicting the occurrence of AD. Our study supports the hypothesis that a decrease in antioxidants and an increase in oxidative damage are linked to AD.
Assuntos
Doença de Alzheimer/sangue , Doença de Alzheimer/diagnóstico , Antioxidantes/metabolismo , Homocisteína/sangue , Estresse Oxidativo/fisiologia , Idoso , Idoso de 80 Anos ou mais , Doença de Alzheimer/fisiopatologia , Biomarcadores/sangue , Estudos Transversais , Feminino , Humanos , Masculino , Testes NeuropsicológicosRESUMO
BACKGROUND/AIM: There is growing consensus in the literature that inflammation plays a significant role in the pathophysiology of Alzheimer's disease (AD). The blood neutrophil-lymphocyte ratio (NLR) is a new, inexpensive and easily applicable marker of inflammation. The aim of this study was to investigate the association between NLR, as an inflammatory biomarker, and AD. METHODS: 241 AD patients and 175 patients with normal cognitive function were evaluated in this study. RESULTS: The mean ± SD NLR of AD patients was significantly higher than that of patients with normal cognitive function (3.21 ± 1.35 vs. 2.07 ± 0.74, p < 0.001, respectively). Receiver operating characteristic curve analysis suggested that the optimum NLR cutoff point for AD was 2.48 with 69.29% sensitivity, 79.43% specificity, 82.30% positive predictive values and 65.30% negative predictive values. Logistic regression analysis showed that elevated NLR (OR: 4.774, 95% CI: 2.821-8.076, p < 0.001) was an independent variable for predicting AD. CONCLUSION: Elderly people with AD have higher NLR than healthy controls. Elevated NLR levels are usually considered as an inflammatory marker. The results of this study suggested that inflammation plays a role in the pathogenesis of AD.
Assuntos
Doença de Alzheimer/sangue , Inflamação/sangue , Linfócitos , Neutrófilos , Idoso , Idoso de 80 Anos ou mais , Doença de Alzheimer/complicações , Biomarcadores , Estudos de Casos e Controles , Feminino , Humanos , Inflamação/complicações , Contagem de Leucócitos , Contagem de Linfócitos , Masculino , Valor Preditivo dos Testes , Curva ROCRESUMO
Previous studies showed oxidative stress had an important impact on osteoclastic and osteoblastic functions. Oxidative stress or low levels of antioxidants are supposed to reduce BMD and cause osteoporosis. hcy, gamma glutamyltransferase (GGT), uric acid, albumin and total bilirubin are simple laboratory parameters that are related with oxidative stress. In this study we compare the serum hcy and antioxidant levels in patients with osteoporosis, osteopenia and control subjects. A total of 2190 elderly persons (1348 patients with osteoporosis, 643 patients with osteopenia and 199 control subjects) who were referred to the outpatient clinic of the Department of Internal Medicine, Division of Geriatric Medicine at Hacettepe University Hospital for comprehensive geriatric assessment were included in this cross-sectional study. Mean age of subjects were 72.30 ± 6.34 in osteoporosis group, 71.92 ± 6.90 in osteopenia and 71.86 ± 5.88 in control group (p: 0.260). Multivariate regression analysis revealed that hypertension (HT) (OR: 0.675, 95% CI: 0.534-0.854, p: 0.001), diabetes mellitus (DM) (OR: 1.669, 95% CI: 1.301-2.142, p: <0.001), age (OR: 1.025, 95% CI: 1.006-1.044, p: 0.009), male gender (OR: 0.451, 95% CI: 0.358-0.569, p<0.001), uric acid (OR: 0.893, 95% CI: 0.837-0.952, p: 0.001), hcy (OR: 1.042, 95% CI: 1.023-1.061, p<0.001), albumin (OR: 0.521, 95% CI: 0.376-0.724, p<0.001), GGT (OR: 1.010, 95% CI: 1.003-1.017, p: 0.003), creatinine (OR: 0.630, 95% CI: 0.459-0.864, p: 0.004) were independent variables predicting the occurrence of osteoporosis. This study shows there is an imbalance between natural antioxidative and oxidative markers in patients with osteoporosis. Higher serum uric acid and albumin levels are associated with a lower prevalence of osteoporosis whereas higher hcy and GGT levels are associated lower BMD and higher osteoporosis prevalence.
Assuntos
Densidade Óssea , Homocisteína/sangue , Estresse Oxidativo , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Biomarcadores/sangue , Doenças Ósseas Metabólicas/sangue , Doenças Ósseas Metabólicas/epidemiologia , Creatinina/sangue , Estudos Transversais , Diabetes Mellitus/sangue , Diabetes Mellitus/epidemiologia , Feminino , Avaliação Geriátrica/estatística & dados numéricos , Humanos , Hipertensão/sangue , Hipertensão/epidemiologia , Masculino , Prevalência , Albumina Sérica/análise , Albumina Sérica/metabolismo , Fatores Sexuais , Ácido Úrico/sangueRESUMO
BACKGROUND/AIM: Dementia is one of the most common health problems in the world. Alzheimer's disease (AD) is the most common form of dementia. The relation between blood pressure (BP) and dementia has been the subject of numerous epidemiological studies, and midlife hypertension (HT) is a risk factor for AD. The association between BP and risk of dementia is lower in the older population. The aim of this study was to examine the association between the prevalence of HT and AD in elderly individuals. METHODS: In this cross-sectional study, 193 patients with AD and 1,860 patients with normal cognitive function were evaluated. RESULTS: The prevalence of HT was lower in the AD group (60.6 vs. 70.5%; p = 0.005). In multivariate analysis, AD was found to be negatively correlated with HT (OR = 0.649; 95% CI 0.461-0.916). CONCLUSION: The prevalence of HT was lower in patients with AD compared to subjects without AD. Physicians who deal with AD patients must keep in mind that the need for antihypertensive medication may decline during the dementia process.
Assuntos
Doença de Alzheimer/epidemiologia , Hipertensão/epidemiologia , Idoso , Análise de Variância , Anti-Hipertensivos/uso terapêutico , Contagem de Células Sanguíneas , Análise Química do Sangue , Pressão Sanguínea/fisiologia , Estudos Transversais , Feminino , Humanos , Hipertensão/tratamento farmacológico , Lipídeos/sangue , Masculino , Testes Neuropsicológicos , Análise de Regressão , Fatores de RiscoRESUMO
Cardiovascular disease (CVD) and OP are common age-related conditions. In both cross-sectional and longitudinal epidemiologic studies, low bone mass has been related to increased frequency of CVD. But available data in geriatric population is limited. In this study we aimed to seek the possible relationship between CAD and low bone mineral density (BMD) in a large number of geriatric patients. A total of 2235 patients aged 65 years or more were included in this cross-sectional study. All patients underwent a complete geriatric assessment and evaluated for CAD and cardiovascular risk factors. BMD was measured by dual-energy X-ray absorptiometry at the lumbar spine (L1-L4) and femoral neck. BMD results were classified into three groups; normal (T-score: ≥-1.0×S.D.), osteopenia (T-score between -1.0 and -2.5×S.D.), and OP (T-score: ≤-2.5×S.D.). CAD was present in 397 (29.7%) of 1335 patients with OP, in 199 (27.4%) of 726 patients with osteopenia and in 34 (19.5%) of 174 patients with normal BMD. Multivariate regression analysis revealed that presence of OP or osteopenia increased the prevalence of CAD as an independent correlate (OR=1.643; 95% CI=1.068-2.528, p=0.030). This study highlights the need for careful evaluation of elderly patients with low BMD for possible CAD.
Assuntos
Comorbidade , Doença da Artéria Coronariana/epidemiologia , Osteoporose/epidemiologia , Absorciometria de Fóton , Idoso , Idoso de 80 Anos ou mais , Doenças Ósseas Metabólicas/diagnóstico por imagem , Doenças Ósseas Metabólicas/epidemiologia , Estudos Transversais , Feminino , Colo do Fêmur/diagnóstico por imagem , Avaliação Geriátrica/estatística & dados numéricos , Humanos , Vértebras Lombares/diagnóstico por imagem , Masculino , Osteoporose/diagnóstico por imagem , Prevalência , Fatores de RiscoRESUMO
Strontium ranelate is claimed to be related with increased risk of thromboembolic events. No explanation of this increased incidence of thromboembolism has been identified. However, growing evidence has clearly demonstrated the involvement of blood rheology in any thrombotic process. The aim of this study was to assess hemorheological changes with strontium ranelate treatment in elderly women with osteoporosis. This study was designed in a prospective manner. Twenty-two elderly women diagnosed with osteoporosis were included. During a 2-month treatment period, participants received strontium ranelate 2g/day. Hemorheological parameters including erythrocyte deformability, erythrocyte aggregation and plasma viscosity were measured before and after 2 months therapy with strontium ranelate. The median age of the patients was 70.0 (range=65-80) years. After 60 days of treatment, there was no statistically significant change in hemorheological parameters. None of the subjects developed clinical venous thromboembolic event (VTE) during the 2-month period of strontium ranelate treatment. Our study demonstrated that in elderly women, treatment of osteoporosis with strontium ranelate did not change hemorheological parameters over 2 months of time. However, its long-term effects on hemorheologic parameters should be evaluated further with a larger sample.
Assuntos
Conservadores da Densidade Óssea/farmacologia , Compostos Organometálicos/farmacologia , Osteoporose/tratamento farmacológico , Tiofenos/farmacologia , Tromboembolia/induzido quimicamente , Idoso , Idoso de 80 Anos ou mais , Viscosidade Sanguínea/efeitos dos fármacos , Conservadores da Densidade Óssea/uso terapêutico , Eritrócitos/efeitos dos fármacos , Feminino , Humanos , Compostos Organometálicos/uso terapêutico , Estudos Prospectivos , Tiofenos/uso terapêuticoRESUMO
Vascular risk factors play a significant role in the pathogenesis and progression of AD. MPV is an index of platelet activation and may be a potential marker of inflammation to demonstrate the vascular damage in AD. The aim of the present study is to assess whether platelet volume would be useful in predicting vascular damage in AD. A total of 126 patients with AD (male/female: 44/82, mean age 76.2 ± 6.8 years) and 286 patients as controls with normal cognitive function (male/female: 123/163, mean age 75.2 ± 6.3 years) were enrolled in this cross-sectional study. MPV values were determined for all study participants. Mini-Mental State Examination (MMSE) and clock drawing tests (CDT) were performed for cognitive assessment, DSM-IV and NINCDS-ADRDA criteria were used for diagnosis of AD. The mean MPV values were significantly higher in AD group (8.46 ± 1.15 vs. 8.17 ± 0.90; p=0.011). In this study, significantly higher MPV values in patients with AD have been detected. Since increased MPV levels are usually considered as a vascular risk factor, the results of this study suggested the role of platelet activation in the vascular pathogenetic basis of AD.
Assuntos
Doença de Alzheimer/sangue , Plaquetas/patologia , Doenças Vasculares/sangue , Doenças Vasculares/epidemiologia , Idoso , Idoso de 80 Anos ou mais , Tamanho Celular , Estudos Transversais , Feminino , Humanos , Masculino , Testes Neuropsicológicos , Ativação Plaquetária , RiscoRESUMO
BACKGROUND & AIMS: Older adults are poorly assessed for malnutrition risk although malnutrition is not an uncommon problem in this population. The aim of this study was to determine the malnutrition risk and its correlates in geriatric outpatients. METHOD: The study was performed in 2327 patients > or =65 years old who were admitted to our Geriatric Medicine outpatient clinic. Together with comprehensive geriatric assessment, nutritional assessment with short version of mini nutritional assessment test (MNA-SF) was performed. MNA-SF score < or =11 was determined as malnutrition risk. RESULTS: Mean age of patients was 72.14+/-6.11 and 1479 (63.6%) were female. Mean MNA-SF score was 12.31+/-2.18. The number of patients with MNA-SF score < or =11 was 651 (28%). Depression, haematocrit, plasma fasting glucose, albumin, erythrocyte sedimentation rate, instrumental activities of daily living scores and bone mineral density measured from total femur were found to be significantly associated with malnutrition risk. CONCLUSION: In this study malnutrition risk was detected in 651 (28%) patients. This ratio was similar to the literature. In older adults malnutrition risk is found to be increased due to majority of chronic illnesses and physical dependency. In conclusion, nutritional assessment should be a part of comprehensive geriatric assessment.
Assuntos
Desnutrição/complicações , Desnutrição/epidemiologia , Avaliação Nutricional , Atividades Cotidianas , Idoso , Idoso de 80 Anos ou mais , Glicemia , Sedimentação Sanguínea , Densidade Óssea , Estudos Transversais , Depressão/complicações , Feminino , Glicoproteínas/sangue , Hematócrito , Humanos , Masculino , Desnutrição/sangue , Ambulatório Hospitalar , Medição de Risco , Fatores de Risco , Albumina Sérica , Albumina Sérica HumanaRESUMO
The ESR is commonly used to assess the acute phase response. It is most useful among patients in whom the probability of disease is moderate following initial history-taking and examination. In this study, we examined retrospectively the patients admitted to our hospital to lighten the cause of a high ESR and accompanying anemia and compared the results between the geriatric population and younger adults. There were 139 patients between ages of 16 and 89 years. Of them, 51.7% were elderly. In 80 patients (57.6%) a specific underlying pathology as a possible cause of elevated ESR was found. Malignancy was the leading cause (21.6%), followed by infectious disorders (10.1%), collagen vascular diseases (9.4%), and non-neoplastic hematologic disorders (5.0%). In 59 patients (42.4%) no specific pathology could be found. There were no statistically significant differences between elderly and non-elderly patients according to the diagnostic groups. Elevated ESRs, while more prevalent in the elderly than in younger individuals, have a similar pathological significance. But as clinical conditions in the elderly are usually obscure, we should be more careful to investigate the issue of high ESR in geriatric population, even when they are asymptomatic.